Iowa Chapter

Patient Education

The Leukemia & Lymphoma Society (LLS) sponsors free community-based education programs designed for patients and their families.

National and local experts, including doctors and other healthcare professionals, lead these programs, described below. They offer education and information that will deepen the public's understanding of treatment options and strengthen decision-making and coping skills related to the many aspects of survivorship.


Upcoming programs:

Get the Latest Information About New Cancer Treatments

September 30, 2014, 5:30 PM: Registration

6-8PM: Complimentary hors d'oeurves and program

Atrium at UnityPoint Health - St. Luke's

Sioux City, IA

This program discusses:

  • Steps to take to help you make treatment decisions
  • Questions to ask about benefits and risks of standard treatments and treatments under study in clinical trials
  • How new blood cancer treatments are developed and approved
  • How to sort out the myths from the facts about clinical trials
  • How to locate clinical trials that may be right for you
  • How The Leukemia & Lymphoma Society can help

Also featured will be a panel of patients who have participated in clinical trials, a special guest from national Leukemia & Lymphoma Society, and free gifts.


Supported by grants from Celgene Corporation and Millennium Pharmaceuticals, Inc.

To register, click here.

Staying Connected: Facilitating the Learning Experience During and After Cancer Treatment

This program discusses:

  • Cancers that affect children, adolescents, and young adults (AYAs)
  • Side effects, long term and late effects of childhood/AYA cancer treatment
  • Challenges for survivors throughout their education
  • Laws that protect childhood/AYA cancer survivors' rights
  • Strategies to help meet the students' short- and long-term educational needs
  • Resources that support schools and families, including those from The Leukemia & Lymphoma Society

Myeloma:  Diagnosis and Treatment

This program discusses:

  • An overview of myeloma
  • Current and emerging drug therapies and stem cell transplantation
  • Disease and treatment-related side effects
  • Emotional aspects and resources available for support
  • Clinical trial options for myeloma patients
  • Question-and-answer session

For information, contact Wendy Sontag at (800) 347-0174 or email

last updated on Tuesday, September 16, 2014